Amy Zheng is an integrative neuroscientist specializing in brain injury rehabilitation and precision medicine. Her research recognizes the interconnection between brain and body systems, employing multimodal approaches including neuroimaging, neuromodulation, wearable technologies, genetic profiling, blood biomarkers, and neuropsychological assessments to develop comprehensive biomarkers that enhance clinical diagnosis and personalized rehabilitation strategies. With expertise spanning both academic and industry settings, she has investigated diverse neurological conditions including Parkinson’s disease, disorders of consciousness, stroke, traumatic brain injury, and long COVID. As co-founder of a precision medicine startup leveraging consumer genetics for personalized health insights, Amy brings practical industry experience to translational neuroscience, focusing on bridging laboratory discoveries with real-world clinical applications to optimize recovery outcomes.